Eric Anthony Murphy's most recent trade in Kinnate Biopharma Inc was a trade of 60,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kinnate Biopharma Inc | Eric Anthony Murphy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) |